Global healthcare reach QuickSTAT serves pharma and biotech clients across more than 150 countries, presenting opportunities to expand or optimize global cold chain partnerships, regulatory-compliant shipping, and decentralized trial logistics for existing and new customers.

Life cycle logistics With capabilities spanning R&D through commercialization and even organ/tissue/blood transport, there is potential to upsell end-to-end logistics programs, risk mitigation services, and value-added solutions for trial sponsors and manufacturers.

Time sensitive focus Specialization in time- and temperature-sensitive shipments positions QuickSTAT to address high-pressure temperature control needs, enabling cross-sell of expedited clinical materials, gene and cell therapy logistics, and urgent patient-supply solutions.

Technology advantage Leveraging QuickOnline 2.0 and advanced IT-driven logistics can be a selling point for clients seeking visibility, real-time tracking, and compliant data telemetry; offer demonstrations or pilots to convert prospects into tech-enabled contracts.

Decentralized trials growth Experience supporting virtual and decentralized trials suggests opportunities to partner with sponsors and CROs on direct-to/from-patient supply chains, expanding services into remote-site logistics and patient-centric distribution networks.